Cargando…
Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome
BACKGROUND: Tumor glycolysis is a target for cancer chemotherapy. Methylglyoxal (MG) is a reactive metabolite formed mainly as a by-product in anaerobic glycolysis, metabolized by glyoxalase 1 (Glo1) of the glyoxalase system. We investigated the role of MG and Glo1 in cancer chemotherapy related in...
Autores principales: | Alhujaily, Muhanad, Abbas, Hafsa, Xue, Mingzhan, de la Fuente, Alberto, Rabbani, Naila, Thornalley, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591171/ https://www.ncbi.nlm.nih.gov/pubmed/34790575 http://dx.doi.org/10.3389/fonc.2021.748698 |
Ejemplares similares
-
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
por: Rabbani, Naila, et al.
Publicado: (2016) -
Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes
por: Rabbani, Naila, et al.
Publicado: (2011) -
Intracellular Accumulation of Methylglyoxal by Glyoxalase 1 Knock Down Alters Collagen Homoeostasis in L6 Myoblasts
por: Stratmann, Bernd, et al.
Publicado: (2017) -
Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022) -
Glycolytic overload-driven dysfunction of periodontal ligament fibroblasts in high glucose concentration, corrected by glyoxalase 1 inducer
por: Ashour, Amal, et al.
Publicado: (2020)